Science Explorer Back to mapMap
Discussion
Researcher · German Breast group · Germany

Sibylle Loibl

Sibylle Loibl publishes mostly in Oncology, Cancer Research and Pulmonary and Respiratory Medicine, on topics such as Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research and Advanced Breast Cancer Therapies.

ORCID 0000-0001-6488-4958 OpenAlex
World rank
#39,027
of 7,710,434 ranked researchers
Rank in Germany
#2,266
of 364,343
Works
1,513
Citations
99k
Citations per work
65.6
h-index
132
i10-index 507Top 0.1% in Oncology
Sibylle Loibl

What does Sibylle Loibl research?

Sibylle Loibl's work is mostly in Medicine (51%), Biochemistry, Genetics and Molecular Biology (31%).

Health Sciences: 769 works · 50.8% of their workMedicine: 769 works · 50.8% of their workOncology: 499 works · 33.0% of their workPulmonary and Respiratory Medicine: 198 works · 13.1% of their workPathology and Forensic Medicine: 71 works · 4.7% of their workLife Sciences: 463 works · 30.6% of their workBiochemistry, Genetics and Molecular Biology: 463 works · 30.6% of their workCancer Research: 319 works · 21.1% of their workMolecular Biology: 74 works · 4.9% of their workGenetics: 70 works · 4.6% of their workEverything else: 281 works · 18.6% of their workTHEIR WORKSibylle Loibl1,513works
Life Sciences31%Health Sciences51%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine76950.8%
    1. Biochemistry, Genetics and Molecular Biology46330.6%
  3. Everything else28118.6%
  1. 1Oncology33% of their works
  2. 2Cancer Research21% of their works
  3. 3Pulmonary and Respiratory Medicine13% of their works
  4. 4Molecular Biology5% of their works
  5. 5Pathology and Forensic Medicine5% of their works
  6. 6Genetics5% of their works

Research topics

Which keywords describe Sibylle Loibl's research?

The keywords of their largest research topics: Breast Cancer, Metastatic Breast Cancer, Breast Tumours, Gene Expression, Chemotherapy, HER2, Trastuzumab and CDK4/6 Inhibitors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Breast Cancer8234 topics
  2. Metastatic Breast Cancer5952 topics
  3. Breast Tumours5381 topic
  4. Gene Expression5381 topic
  5. Chemotherapy4012 topics
  6. HER23101 topic
  7. Trastuzumab3101 topic
  8. CDK4/6 Inhibitors2991 topic
  9. Palbociclib2991 topic
  10. Chemotherapy-Induced Peripheral Neuropathy2961 topic
  11. Taxanes2961 topic
  12. Mammography1231 topic
  13. Ultrasound1231 topic
  14. Cancer Genomics961 topic
  15. Mutational Signatures961 topic
  16. Cancer911 topic
  17. Obesity911 topic
  18. Immune Checkpoint Blockade761 topic
  19. PD-1 and PD-L1761 topic

Where does Sibylle Loibl work?

Sibylle Loibl's main affiliation in the publication record is German Breast group, Germany.

How many publications and citations does Sibylle Loibl have?

OpenAlex counts 1,513 works and 99,255 citations for Sibylle Loibl, an h-index of 132, ranking #39,027 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Sibylle Loibl

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Sibylle Loibl. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.